Viewing Study NCT05815160


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2025-12-27 @ 6:06 AM
Study NCT ID: NCT05815160
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-01
First Post: 2023-03-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Sponsor: Debiopharm International SA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module